The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 995
ISSUE 995
February 28, 1997
Issue 995
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Reteplase (Retavase)
February 28, 1997 (Issue: 995)
Reteplase (Retavase - Boehringer Mannheim), a recombinant protein derivative of human tissue plasminogen activator (t-PA), has been marketed in the USA for thrombolysis in patients with acute myocardial infarction.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.